DESTINA Genomics Ltd

DESTINA Genomica is the only company capable of directly detecting small RNA without the need for laborious and inefficient processes such as extraction and amplification. Furthermore, its technology enables the development of assays that can simultaneously detect proteins and nucleic acids.

La compañía de Granada con sello de calidad del Consejo Europeo de Innovación | Ideal Destina Genómica SL es reconocida por Europa con un distintivo que le abre la puerta a captar hasta dos millones en ayudas por parte de las administraciones

Salvatore Pernagallo

Great talk by Piero Conca from COGENTECH at BIC Granada while visiting DESTINA GENOMICA. Piero is currently on his secondment at UGR as part of our EU project . It was nice learning how AI can support biomarker discovery.

We are delighted to announce our latest publication! Special thanks to the diaRNAgnos consortia for their collaboration and the Marie Curie funding program for their support.

Stay tuned for more updates!

www.sciencedirect.com

Exciting news! DESTINA is attending Galicia Biodays 2024! 🚀

We’re looking forward to exploring new opportunities and opening a new chapter in our journey.

Happy International Women's Day! Today at Manuel de Falla High School (, Spain), we celebrated with Salvatore Pernagallo and Bahareh Soleimanpour, who gave an inspiring talk about the incredible women leading the charge in science. They presented our contribution to fight against colorectal cancer, highlighting the groundbreaking work of ColoMARK. We hope it was inspiring for the many interested students at the institute who may soon join our efforts by pursuing careers in science. Once again, cheers to the women who contribute to science every day with their brilliance and determination! 💪

At DESTINA, our daily work is fueled by passion and guided by a shared vision. We're not just a team, but a community united in our pursuit of excellence and innovation.

Every project is an opportunity to embrace challenges, grow together, and make a meaningful impact. Our diverse perspectives enrich our journey, pushing us towards our common horizon.

Thank you to everyone who is part of this journey. Your passion and support make all the difference. Together, let's continue to turn our shared vision into reality.

Salvatore Pernagallo

Just concluded a productive wrap-up meeting for the Combo LiverAce project at AIT Vienna. Exciting progress made and collaborative efforts shining through! Salvatore Pernagallo

Thrilled to announce that DESTINA played a pivotal role at the ColoMARK meeting in Doblin, contributing expertise to advance liquid biopsy in colorectal cancer. Their presence added significant value, reinforcing the commitment to revolutionize diagnostics and treatment. Salvatore Pernagallo

🎉 We're thrilled to announce that DESTINA has been awarded as one of the poster winners at ! Our COMBO LiverAce represents a breakthrough in the Luminex system by enabling simultaneous detection of nucleic acids & proteins AIT Tomorrow2day Salvatore Pernagallo

We are championing assays that simultaneously detect nucleic acids and proteins, leading the way in this field.

Stay tuned as we continue to transform this field with as our strategic partner.

Join us at to explore how COMBO LiverAce is revolutionizing the field of liquid biopsies. Witness the future of personalized medicine as we aim to enhance drug safety protocols. Austrian Institute of Technology Salvatore Pernagallo

Join Us at DESTINA Genomica SL!
We're hiring an Assay Development Scientist!
Location: Granada, Spain.
Find additional information and the application method attached.
Share with friends! 🔄 Or tag someone perfect for the job. 🎯

https://www.uma.es/sala-de-prensa/noticias/especialistas-del-proyecto-de-cooperacion-internacional-en-investigacion-eureka-se-reunen-en-la-uma/

Especialistas del proyecto de cooperación internacional en investigación ‘Eureka’ se reúnen en la UMA - Universidad de Málaga Se ha detectado un cierre de sesión de su cuenta desde otra aplicación federada con iDUMA o, simplemente, su sesión ha caducado.

🌐 International Collaboration for Liver Health 🏥: The EUREKA Project "LiverAce E!114589" recently convened in Malaga, uniting experts from , , , and hosted by Professors Maribel Lucena and Raul Andrade
Together, we're transforming liver healthcare! 🩺 🌟

On September 29, 2023, DESTINA proudly took part in the exhilarating European Researchers' Night in Granada. We shared the scientific insights from our two EU projects, and , with an enthusiastic audience. Thank you for joining us on this voyage of exploration. Stay connected for more thrilling updates from DESTINA!

As a group of colleagues at DESTINA Genomics Ltd, we had an unforgettable evening prior to our company's spring board meeting in Granada. We savored a delicious meal with a breathtaking view of the Alhambra palace, and the lively conversation and jovial atmosphere made for a truly magical evening. We feel grateful for the opportunity to have shared such a wonderful experience together and to be planning a bright future for DESTINA.

Exciting news! Our latest paper entitled 'SARS-CoV-2 viral RNA detection using the novel CoVradar device associated with the CoVreader smartphone app' has been published. Learn how DESTINA technology is helping in the fight against COVID-19. "
Salvatore Pernagallo

Article link:
https://doi.org/10.1016/j.bios.2023.115268

Greetings from Nashville! We are excited to be at the annual meeting this week. Today, we are presenting a poster with at location P156, featuring our assay for detecting the liver-specific miR-122 in the SMCxPro® platform.

The miR-122 assay is ideal for drug development and adds value to standard protein biomarkers. The assay quantifies miR-122 directly from biological sources without the need for extraction or amplification. Sample service testing is available through
CADI Lab.

Salvatore Pernagallo, Enrique Cruz Freestyle

An industry-focused research position is now available at DESTINA Genomica S.L. If you are interested to contribute with your research to discover novel biomarkers for colorectal cancer and develop novel liquid biopsy technologies, go and check out our outstanding DC6 project position to undertake your industrial PhD in! The candidate will be enrolled in a doctoral programme at Universidad de Granada!

Doctoral candidate positions MSCA Doctoral Network ColoMARK COLOMARK Network We are seeking 9 highly motivated fellows to pursue a career in science, obtain a PhD abroad and work in one of the three-year research projects we are offering under the Doctoral Network Marie Skłodowska-Curie Action ColoMARK.

https://destinagenomics.com/diagnosing-alzheimers-disease-project-granted-with-more-than-e1-3-million-in-aid-under-the-colaboracion-publico-privada-program/

Diagnosing Alzheimer’s Disease – Project granted with more than €1.3 million in aid under the Colaboración Público Privada Program Destina Genomica SL is part of a consortium formed by the Foundation for Biomedical Research of the Ramón y Cajal University Hospital (Madrid, Spain), the Advanced Photonic and Biofunctional Materials Group of the UAM (Autonomous University of Madrid, Spain) and led by the Spanish company Mecwins S...

Salvatore Pernagallo

A big thank to CIBIO - UniTrento for inviting our Operations Director (Salvatore Pernagallo) to present our novel solutions for miRNAs’ analysis in biological fluids. It was also the chance to bring the latest updates re our project. Hope you all have enjoyed the seminar.

A big thank to CIBIO - UniTrento for inviting our Operations Director (Salvatore Pernagallo) to present our novel solutions for miRNAs’ analysis in biological fluids. It was also the chance to bring the latest updates re our project. Hope you all have enjoyed the seminar.

https://www.linkedin.com/posts/destina-genomics-ltd%2E_ultrasensitive-immunoassays-the-power-of-activity-6782584228556148737-qOqV

DESTINA Genomics Ltd. on LinkedIn: Ultrasensitive Immunoassays: The Power of Single Molecule Counting A Virtual Symposium On Ultrasensitive Immunoassays: The Power of Single Molecule Counting (SMC™) Technology organised by MilliporeSigma. LabRoots On ...